Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Devlin, RG"'
Publikováno v:
British Journal of Clinical Pharmacology; 1981, Vol. 12 Issue 3, p393-396, 4p
Publikováno v:
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.). 145(2)
SummaryThe cyclophosphamide analogues ifosfamide and trofosfamide suppressed the mixed lymphocyte reaction in mice to about the same extent as did cyclophosphamide when the dose of the three drugs was 100 mg/kg intraperitoneally. The suppressive acti
Publikováno v:
Transplantation. 17(1)
Publikováno v:
British Journal of Clinical Pharmacology; 1985, Vol. 19 Issue 4, p509-511, 3p
Autor:
Granade CJ; Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop H24-4, Atlanta, GA 30326, United States; Oak Ridge Institute for Science and Education, U.S. Department of Energy, P.O. Box 117, Mail stop 36, Oak Ridge, TN 37831, United States; IHRC Inc, 2 Ravinia Dr Suite 1200, Atlanta, GA 30346, United States. Electronic address: ori9@cdc.gov., Parker Fiebelkorn A; Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop H24-4, Atlanta, GA 30326, United States. Electronic address: dez8@cdc.gov., Black CL; Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop H24-4, Atlanta, GA 30326, United States. Electronic address: zwc0@cdc.gov., Lutz CS; Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop H24-4, Atlanta, GA 30326, United States; Oak Ridge Institute for Science and Education, U.S. Department of Energy, P.O. Box 117, Mail stop 36, Oak Ridge, TN 37831, United States; Department of International Health, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD 21205, United States. Electronic address: clutz8@jhu.edu., Srivastav A; Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop H24-4, Atlanta, GA 30326, United States; Leidos Inc, 2295 Parklake Dr NE, Atlanta, GA 30345, United States. Electronic address: xbs2@cdc.gov., Bridges CB; Berry Technology Solutions, Inc, 19 E. Broad St, Suite B, Newnan, GA 30263, United States; Immunization Action Coalition, 2550 University Ave W, Suite 415, St. Paul, MN 55114, United States. Electronic address: carolyn.bridges@immunize.org., Ball SW; Abt Associates Inc, 10 Fawcett St, Suite 5, Cambridge, Massachusetts, United States; Westat, 1600 Research Blvd, Rockville, MD 20850, United States. Electronic address: SarahBall@westat.com., Devlin RG; Abt Associates Inc, 10 Fawcett St, Suite 5, Cambridge, Massachusetts, United States. Electronic address: Rebecca_Devlin@abtassoc.com., Cloud AJ; Abt Associates Inc, 10 Fawcett St, Suite 5, Cambridge, Massachusetts, United States. Electronic address: Ann_Cloud@abtassoc.com., Kim DK; Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop H24-4, Atlanta, GA 30326, United States; United States Department of Health and Human Services, 200 Independence Ave S.W., Washington, DC. 20201, United States. Electronic address: David.Kim@hhs.gov.
Publikováno v:
Vaccine [Vaccine] 2020 Jul 14; Vol. 38 (33), pp. 5305-5312. Date of Electronic Publication: 2020 Jun 22.
Autor:
Lutz CS; Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia; Oak Ridge Institute for Science and Education, U.S. Department of Energy, Washington, District of Columbia. Electronic address: nfi5@cdc.gov., Kim DK; Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia., Black CL; Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia., Ball SW; Abt Associates, Cambridge, Massachusetts., Devlin RG; Abt Associates, Cambridge, Massachusetts., Srivastav A; Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia; Leidos Inc., Atlanta, Georgia., Fiebelkorn AP; Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia., Bridges CB; Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia; Berry Technology Solutions, Inc., Peachtree City, Georgia.
Publikováno v:
American journal of preventive medicine [Am J Prev Med] 2018 Sep; Vol. 55 (3), pp. 308-318. Date of Electronic Publication: 2018 Jul 24.
Publikováno v:
Immunopharmacology [Immunopharmacology] 1981 Jun; Vol. 3 (2), pp. 147-59.
Publikováno v:
Infection and immunity [Infect Immun] 1979 Jan; Vol. 23 (1), pp. 133-9.
Autor:
Devlin RG; Biochemistry Department, Mead Johnson Research Center, Evansville, Indiana 47721., McCurdy JD, Baronowsky PE
Publikováno v:
The Journal of experimental medicine [J Exp Med] 1974 Jan 01; Vol. 139 (1), pp. 230-7.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 1984 Nov; Vol. 73 (11), pp. 1571-5.